Because most patients placed on the waiting list for kidney transplantation are on dialysis, these changes likely affect the prognosis for prospective kidney transplant candidates. In addition, there have also been significant changes in regulatory oversight of transplant centers in the past decade that may have affected selection and management of the kidney transplant candidate population. [4] [5] [6] There are numerous reasons that it is important to understand potential changes in outcomes for the transplant candidate population. First, these data provide important information for prospective patients and caregivers regarding their prognosis and opportunities to receive a transplant. Second, the characteristics and outcomes of the candidate population are used for ongoing policy development (eg, organ allocation, simulation modeling, and regulatory oversight) and incorporation of any potential secular changes is critically important toward informing prior and prospective policies. These data can also be used to assess changes in clinical practice and processes of care. Furthermore, prior research studies that were based on historical data may need to be reexamined to reflect the contemporary epidemiology of the candidate population.
We conducted a study to evaluate secular changes in outcomes of the national kidney transplant candidate population. First, we sought to assess changes in mortality of the transplant candidate population over time. Second, we examined potential alterations in rates of transplantation and waitlist removals following placement on the waiting list. Finally, we evaluated factors that potentially modified changes in mortality that may further elucidate mechanisms associated with observed differences. Cumulatively, our intent was to assess patterns in the health and prognosis of the transplant candidate population that may inform prospective policy, decisionmaking, clinical care, and research.
| ME THODS
The data source for this study was the Scientific Registry of Transplant Recipients (SRTR). The SRTR data system includes data on all donor, waitlisted candidates, and transplant recipients in the United States, submitted by the members of the Organ Procurement and Transplantation Network (OPTN), and has been described elsewhere. 7 The Health Resources and Services Administration (HRSA), the US Department of Health and Human Services provides oversight to the activities of the OPTN and SRTR contractors.
We examined adult patients (age ≥18) based on their primary Five-year estimates were not depicted for the final era due to nonlinear rates of events and lack of full follow-up for this cohort.
Differences in descriptive statistics by era of listing were conducted using Kruskal-Wallis, chi-square, analysis of variance (ANOVA), and Fisher exact tests as appropriate. We expressed overall rates as events per follow-up year of time on the waiting list.
In addition, we expressed incidence rates based on events stratified by time following listing to illustrate potential changes in rates after patients' time of placement on the waiting list. Mortality was not censored at the time of waitlist removal, and as such included deaths following delisting. In addition, mortality rates following waitlist removal were evaluated under the condition that the death did not occur on the day of removal. Waitlist removals were specifically defined as those coded for reasons of "too sick" or "other," which represent the preponderance of reasons for removal other than death or transplantation.
Because the primary outcomes were time dependent and also were potentially competing risks, we used multivariable subdistribution hazard ratios to express relative risks and cumulative incidence functions that incorporated competing risks in the analyses. 8 Multivariable models were adjusted for characteristics of the waitlist population at the time of placement; these are depicted in Table 1 . To evaluate the potential for effect modification, we generated models with additional interaction terms for predefined risk factors and tested whether temporal effects were statistically significantly different between strata of the study population. To express annual rates of events graphically we used Loess curves based on smoothed quadratic regression plots. 9 The study was approved by the Cleveland Clinic Institutional Review Board. All analyses were performed in SAS (v. 9.4., Cary, NC).
| RE SULTS

| Study population
The study cohort was comprised of 340 115 patients placed on with the waiting list for their primary listing between 2001 and 2015. The derivation of the study population from the SRTR is displayed in Figure 1 . The number of patients who were placed on the waiting list for their first listing increased over time: n = 70 425 in era 1 as compared to 103 619 in era 4. As depicted in Table 1 
| Unadjusted event rates
The unadjusted rates of the primary outcomes of the study are depicted in Table 2 stratified by era. As illustrated, mortality following placement on the waiting list significantly declined over the TA B L E 1 Demographic characteristics of primary waitlist candidates by era as compared to 14.2/1000 patient years in era 1). Patients who were removed from the waiting list were more likely to be older, male, and have diabetes, with a history of malignancies and peripheral vascular disease, less educated, more prelisting dialysis time, inactively listed, publicly insured, and not working for income (Table S1 ). In addition, increased rates of removal over time were more evident among candidates who were older, had diabetes, were listed as inactive, and with prior malignancies and obese. 
| Mortality and waitlist removal rates following placement on the waiting list
As described previously, mortality rates on the waiting list significantly declined by era. In addition, across all eras, there was a notable increase in mortality rates following patient placement on the waiting list. As depicted in Figure 3 , candidate mortality rates were lowest in the first year following listing in each era. Following the first year, mortality rates steadily increased and were approximately doubled at 5 years following listing. Also described previously, waitlist removal rates significantly increased over the study period. In addition, the rate of waitlist removals significantly increased following placement on the waiting list 
TA B L E 1 (Continued)
across each era (Figure 4) . Rates of removal were approximately 4-fold at 5 years following placement on the waiting list as compared to the initial year of placement.
| Multivariable relative risks of events by era
After multivariable adjustment and accounting for competing risks, the relative risk of mortality within 1 year and 5 years following placement significantly declined (Adjusted Subhazard Ratio
[ASR] = 1.11 and ASR = 1.12 for era 1 vs era 4 for 1-and 5-year mortality, respectively, Table S2 and 3, respectively. We also replicated the primary models using Cox proportional hazard models censoring for competing events rather than using competing risk models. In general, these models all indicated significant associations similar to the current results but with increased point estimates (ie, higher hazard ratios for mortality and transplantation and lower hazard ratios for waitlist removal).
| Effect modification
We evaluated secular trends in 1 year and 5 years to mortality and tested the presence of interactions with predefined subgroups of the waitlist population. These included patients based on gender, age, BMI, diabetes defined as primary diagnosis, preexisting dialysis time, and race/ethnicity. Results of the models for age and gender indicated no statistically significant interactions for trends in mortality declines over time. As depicted in Figure 5A , F I G U R E for patients who were listed preemptively or with <12 months of prelisting dialysis, there were relatively minor changes in mortality risk over the study period. In contrast, for patients with longer preexisting dialysis time at the time of listing (eg, >1 year), there was a dramatic decline in short-and long-term mortality (P-value for interaction < 0.01).
Figure 5B depicts mortality risk by racial grouping. As indicated, mortality rates for Caucasians were relatively stagnant over time, but were markedly reduced for African
Americans over time (P-value for interaction < 0.01). The relative risk of mortality for patients without diabetes remained relatively consistent over the study period but was significantly reduced among patients with diabetes (P-value for interaction < 0.01).
There was also a statistically significant interaction of BMI with year of placement indicating that patients with higher BMI had greater improvement in survival over time than lower weight candidates (data not shown).
| D ISCUSS I ON
The primary findings of the study illustrate significant changes in the prognosis and outcomes of adult solitary kidney transplant candidates in the United States. Over the past 15 years there has been a significant decline in annual mortality rates on the waiting list as The reduction in mortality among ESRD patients was also recently described by Storey et al in the English population. 10 This F I G U R E 3 Mortality rates following placement on the waiting list by era study demonstrated reduction in mortality in the overall dialysis population, and, in addition, a greater estimated decline among patients with diabetes. Moreover, results of this study demonstrated that declines in mortality among patients with diabetes was also evidenced in the general (non-ESRD) population. The current study suggests that the improved survival among candidates was more dramatic among patients with diabetes, and that differences in improvements may be related to overall improved survival among these patients in the United States. 11 Greater survival among African
American dialysis patients relative to Caucasians has been demonstrated in numerous studies, with the additional finding that these differences were most salient in the older population. 12 The current study also indicates that the improvements in survival over time have been more evidenced among African Americans, suggesting that the survival differences by race have been further extended over time.
The lack of documentation noting the specific reasons for removal of candidates from the waiting list limits the ability to infer all the potential causes for the observed increase in rates over time.
However, the risk of removal has dramatically increased, nearly doubling over the study period. A recent study demonstrated that candidate removal rates significantly increase associated with centers that receive low performance evaluations. 13 Thus, one of the sources of increased rates of removal may derive from centers that remove patients who are perceived to be at higher risk more frequently over concerns related to measured performance. 5, 14, 15 The role of changes in candidate selection processes is not clear from the current study, but it is notable that despite some evidence of risk aversion, many traditional risk factors for the candidate population have increased over time (eg, older age, diabetes status, obesity). There may also be increased vigilance among transplant centers regarding the health of the waiting list and more prevalent follow-up of candidate status that led to removal of patients from the waiting list. A notable trend regarding the composition of waitlist removal patients were indications of social risks (eg, working status and insurance type) suggesting non-medical factors as an important driver of waitlist removals.
Although the trends in increased candidate removal have increased over the entire study period, rates may also have increased in more recent years associated with the revised kidney allocation system.
In particular, the new priority given to patients with longer dialysis duration may have led to increased assessment of candidacy (and potential removal) of these patients.
The decline in rates of deceased donor transplantation is expected with the increased number of transplant candidates and the relative stagnation in the annual number of transplants. In addition,
there has been a stagnation in living donor transplant rates nationally. 16 The specific causes for this decline are not known but may It is important to note that the study highlights that the probability of not receiving a transplant for extended periods has markedly increased over time. This is also important given results in the current study that illustrate that both mortality rates and rates of waitlist removal increase substantially following placement. Thus, rather than a consistent risk of mortality and morbidity that may lead to patients removed from the waiting list on dialysis, overall prognoses and maintaining viability as a candidate decline over However, the opportunity to actually receive a donor offer is substantially affected by the increased mortality, and removal rates over time and risks of diminishing health over time are important to consider for clinical and patient decision-making.
Another consideration of the current findings are the implications for prospective research and policy development. It is notable that some of the most seminal and fundamental observational studies that inform practice in transplantation (eg, quantifying the survival advantage of transplantation, identifying eligible patients for high-risk donors, and the effects of wait time) are largely based on historical data, which may need to be reevaluated in contemporary cohorts reflecting changes described in the current results. [18] [19] [20] That is, given the significant shifts in mortality, transplant, and candidate removal rates, studies based on historical candidate populations may not be directly applicable to the current population. Similarly, public policies, simulation models, and clinical practice guidelines that are based on historical cohorts such as organ allocation policy, geographic distribution models, and follow-up protocols that were developed assuming candidate risk from prior years may need to be refreshed with more contemporaneous assumptions. Notably, even the "new" kidney allocation policy derived from data as old as 2007;
thus assumptions based on outcomes of candidates from that era may have changed significantly over the past decade as depicted in the current study. Certainly, dissemination of risks and transplant opportunities for patients are constantly evolving estimates, but the current findings highlight that contemporary outcomes are needed to best inform these decision-making processes. Finally, prospective research identifying specific medical and practice patterns associated with secular changes are important to understand the evolving epidemiology of this population.
There were several interesting methodologic considerations for conducting the study. The issue of competing risks was an immediate consideration due to the conceptual concern of nonrandom censoring (eg, patients who reached transplantation were systematically distinct from patients who were censored for other reasons). As such, our models and estimates incorporated methodology to address these issues. In addition, our analyses indicated that the time to event models were potentially confounded by the duration of follow-up time and the presence of nonlinear effects associated with changes over time. As such, we presented models with different duration of administrative censoring (eg, 1 year and 5 years) and also presented the nonlinear effects in the results that also have potentially important implications. Finally, our hypothesis that effects may be modified by patient characteristics was confirmed and the incorporation of interaction terms in the models depicted highly differential secular effects in subsets of the population.
There are a number of limitations that should be considered with interpretation of these data. Consistent with analysis of retrospective data, the inferences of the study are limited generally to associations
and cannot be ascribed directly to cause and effect relationships.
There are many variables that are not collected in the primary data sources regarding patient characteristics, indications of severity, reasons for waitlist removal, and lack of granularity about existing data elements that may limit the interpretation of certain findings. It is important to note that there is no systematic national data collected about patients who are evaluated for transplantation, and as such, the questions related to the broader population of those patients who could have been selected as transplant candidates over time but
are not listed are not addressable. We also did not include candidates who were placed on the waiting list following primary graft failure.
Although this is an important and growing population, the analysis and outcomes may be distinct in this cohort. We also acknowledge that many of the findings are modified by region and individual trans- 
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